TLR4 and myeloid sarcoma: Indeed, Crowley et al. (2015) recently demonstrated that peripheral blood mononuclear cells (PBMCs) isolated from MS patients are hypersensitive to TLR4 stimulation, promoting a pro-inflammatory signature (Crowley et al., 2015).